Trial Profile
A study to evaluate the efficacy of Riociguat on the excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Sep 2015
Price :
$35
*
At a glance
- Drugs Riociguat (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 08 Sep 2015 New trial record